JP2018517778A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018517778A5 JP2018517778A5 JP2018517499A JP2018517499A JP2018517778A5 JP 2018517778 A5 JP2018517778 A5 JP 2018517778A5 JP 2018517499 A JP2018517499 A JP 2018517499A JP 2018517499 A JP2018517499 A JP 2018517499A JP 2018517778 A5 JP2018517778 A5 JP 2018517778A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- tumor
- virus
- particles
- oncolytic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562182383P | 2015-06-19 | 2015-06-19 | |
| US62/182,383 | 2015-06-19 | ||
| PCT/IB2016/000993 WO2017037523A1 (en) | 2015-06-19 | 2016-06-17 | Compositions and methods for viral embolization |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018517778A JP2018517778A (ja) | 2018-07-05 |
| JP2018517778A5 true JP2018517778A5 (enExample) | 2019-07-18 |
| JP6827467B2 JP6827467B2 (ja) | 2021-02-10 |
Family
ID=58186857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018517499A Active JP6827467B2 (ja) | 2015-06-19 | 2016-06-17 | ウイルス塞栓術のための組成物および方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10517910B2 (enExample) |
| EP (1) | EP3310383B1 (enExample) |
| JP (1) | JP6827467B2 (enExample) |
| KR (1) | KR102735275B1 (enExample) |
| CN (1) | CN108025056B (enExample) |
| AU (1) | AU2016313969B2 (enExample) |
| ES (1) | ES2795010T3 (enExample) |
| WO (1) | WO2017037523A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4122492A1 (en) | 2015-02-25 | 2023-01-25 | Memorial Sloan Kettering Cancer Center | Use of inactivated nonreplicating modified vaccinia virus ankara (mva)as monoimmunotherapy or in combination with immune checkpoint blocking agents for solid tumors |
| KR20180006916A (ko) | 2015-04-17 | 2018-01-19 | 메모리얼 슬로안-케터링 캔서 센터 | 고형 종양에 대한 면역치료제로서 mva 또는 mva델타e3l의 용도 |
| AU2016313969B2 (en) | 2015-06-19 | 2021-12-23 | Sillajen, Inc. | Compositions and methods for viral embolization |
| CN109152815B (zh) | 2016-02-25 | 2022-10-18 | 纪念斯隆凯特琳癌症中心 | 用于癌症免疫治疗的具有胸苷激酶缺失和具有或不具有人flt3l或gm-csf表达的复制型减毒痘苗病毒 |
| WO2017147554A2 (en) | 2016-02-25 | 2017-08-31 | Memorial Sloan-Kettering Cancer Center | Recombinant mva or mvadele3l expressing human flt3l and use thereof as immuno-therapeutic agents against solid tumors |
| CA3031416C (en) * | 2016-07-21 | 2023-09-19 | Kolon Life Science, Inc. | Recombinant vaccinia virus and use thereof |
| CN111107872A (zh) | 2017-05-12 | 2020-05-05 | 纪念斯隆-凯特林癌症中心 | 有用于癌症免疫疗法的牛痘病毒突变体 |
| CN109554353B (zh) * | 2017-09-26 | 2021-08-06 | 杭州康万达医药科技有限公司 | 分离的重组溶瘤痘病毒、药物组合物及其在治疗肿瘤和/或癌症的药物中的用途 |
| KR20190059421A (ko) * | 2017-11-23 | 2019-05-31 | 주식회사 바이오녹스 | 항암바이러스의 간동맥 투여를 이용한 간암 치료방법 |
| SG11202100305SA (en) | 2018-07-13 | 2021-02-25 | Univ Arizona State | Methods of treating cancer with tnf expressing myxoma virus |
| CA3112654A1 (en) | 2018-09-15 | 2020-03-19 | Memorial Sloan Kettering Cancer Center | Recombinant poxviruses for cancer immunotherapy |
| US20240024393A1 (en) * | 2019-01-25 | 2024-01-25 | Virocure, Inc. | Pharmaceutical composition for preventing or treating cancer, comprising squirrel fibroma virus and reovirus |
| US11685904B2 (en) | 2019-02-14 | 2023-06-27 | Ignite Immunotherapy, Inc. | Recombinant vaccinia virus and methods of use thereof |
| CN114615988A (zh) * | 2019-09-02 | 2022-06-10 | 亚利桑那州立大学董事会 | 用黏液瘤病毒治疗癌症的新型溶瘤病毒平台 |
| DE102020101197A1 (de) * | 2020-01-20 | 2021-07-22 | Charité - Universitätsmedizin Berlin | Medizinprodukt zur Arzneimittelabgabe mit verstärkter Wirkung |
| KR20230038496A (ko) | 2020-07-13 | 2023-03-20 | 트랜스진 | 면역 억제의 치료 |
| CN114681393A (zh) * | 2020-12-25 | 2022-07-01 | 上海三维生物技术有限公司 | 溶瘤腺病毒的栓塞剂 |
| WO2023213764A1 (en) | 2022-05-02 | 2023-11-09 | Transgene | Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf |
| WO2023213763A1 (en) | 2022-05-02 | 2023-11-09 | Transgene | Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab |
| CN116942888B (zh) * | 2023-09-11 | 2026-03-24 | 科睿驰（深圳）医疗科技发展有限公司 | 淀粉水凝胶栓塞微球及其制备方法 |
| WO2026041811A1 (en) | 2024-08-23 | 2026-02-26 | Transgene | Recombinant poxvirus and method for regulating the expression of toxic conditional gene products of said recombinant poxvirus in a producing cell |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5073627A (en) | 1989-08-22 | 1991-12-17 | Immunex Corporation | Fusion proteins comprising GM-CSF and IL-3 |
| AU683211B2 (en) | 1992-04-08 | 1997-11-06 | United States of America as represented by The Secretary Department of Health and Human Services, The | Wild-type measles virus glycoproteins: vaccine and detection method therefor |
| FR2736358B1 (fr) | 1995-07-05 | 1997-09-26 | Agronomique Inst Nat Rech | Virus myxomateux recombinant |
| AU8877098A (en) | 1997-09-05 | 1999-03-29 | Nycomed Imaging As | Polymer particles made of polyvinyl alcohol and comprising contrast agent for chemoembolization |
| FR2784580B1 (fr) * | 1998-10-16 | 2004-06-25 | Biosepra Inc | Microspheres de polyvinyl-alcool et procedes de fabrication de celles-ci |
| WO2001072281A2 (en) | 2000-03-24 | 2001-10-04 | Biosphere Medical Inc. | Microspheres for active embolization |
| JP2004510723A (ja) * | 2000-10-06 | 2004-04-08 | ヤゴテック アーゲー | 低下した分子量のアミロペクチンをベースとする精製された澱粉を含む制御放出投与のための生物分解性微粒子 |
| NZ536102A (en) | 2002-05-09 | 2008-01-31 | Oncolytics Biotech Inc | Oncolytic viruses, in particular reovirus, for reducing pain associated with proliferative disorders, particularly with the growth of a solid tumour mass |
| WO2004014314A2 (en) * | 2002-08-12 | 2004-02-19 | David Kirn | Methods and compositions concerning poxviruses and cancer |
| EP1933857A2 (en) * | 2005-09-07 | 2008-06-25 | Jennerex Biotherapeutics ULC | Systemic treatment of metastatic and/or systemically-disseminated cancers using gm-csf-expressing poxviruses |
| US8980246B2 (en) * | 2005-09-07 | 2015-03-17 | Sillajen Biotherapeutics, Inc. | Oncolytic vaccinia virus cancer therapy |
| EP2116256A1 (en) * | 2007-03-01 | 2009-11-11 | Cosmed Pharmaceutical Co., Ltd. | Transdermal immune preparation, method for production of the same, and transdermal immunization method using the same |
| KR20080084528A (ko) * | 2007-03-15 | 2008-09-19 | 제네렉스 바이오테라퓨틱스 인크. | 종양살상형 백시니아 바이러스 암 치료 |
| KR101838472B1 (ko) * | 2009-09-14 | 2018-03-15 | 신라젠(주) | 종양 용해 백시니아 바이러스 병용 암 치료요법 |
| WO2011135734A1 (ja) * | 2010-04-28 | 2011-11-03 | 株式会社アルファ・ナノ・メディカ | ウイルスの複合体、それを含有する治療薬及び治療方法 |
| ES2542242T3 (es) * | 2010-11-29 | 2015-08-03 | Centre Hospitalier Universitaire Vaudois | Composición de quimioembolización que comprende agentes antiangiogénicos |
| US9919047B2 (en) * | 2011-01-04 | 2018-03-20 | Sillajen, Inc. | Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus |
| KR102022952B1 (ko) * | 2011-08-05 | 2019-09-20 | 신라젠(주) | 백시니아 바이러스의 생산을 위한 방법 및 조성물 |
| US20140086976A1 (en) * | 2012-08-20 | 2014-03-27 | Aladar A. Szalay | Compositions containing protein polymers and vaccinia virus, and methods of use thereof |
| US20140194370A1 (en) * | 2013-01-08 | 2014-07-10 | University Of Utah Research Foundation | Silk-elastin like protein polymers for embolization and chemoembolization to treat cancer |
| AU2016313969B2 (en) | 2015-06-19 | 2021-12-23 | Sillajen, Inc. | Compositions and methods for viral embolization |
| HK1255192A1 (zh) * | 2015-09-08 | 2019-08-09 | Sillajen, Inc. | 表达细胞因子和羧酸酯酶的修饰的溶瘤痘苗病毒及其使用方法 |
-
2016
- 2016-06-17 AU AU2016313969A patent/AU2016313969B2/en not_active Ceased
- 2016-06-17 US US15/738,034 patent/US10517910B2/en active Active
- 2016-06-17 ES ES16840890T patent/ES2795010T3/es active Active
- 2016-06-17 CN CN201680048316.5A patent/CN108025056B/zh not_active Expired - Fee Related
- 2016-06-17 WO PCT/IB2016/000993 patent/WO2017037523A1/en not_active Ceased
- 2016-06-17 JP JP2018517499A patent/JP6827467B2/ja active Active
- 2016-06-17 EP EP16840890.4A patent/EP3310383B1/en active Active
- 2016-06-17 KR KR1020187001688A patent/KR102735275B1/ko active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108025056B (zh) | 用于病毒栓塞的组合物和方法 | |
| JP6907283B2 (ja) | ポリマー粒子 | |
| EP2861257B1 (en) | Polymeric treatment compositions | |
| DE60130743T2 (de) | Mikrokugeln zur aktiven embolisierung | |
| EP1687032A1 (en) | Therapeutic regimen for treating cancer | |
| JP2020517272A5 (enExample) | ||
| JP2014523236A5 (enExample) | ||
| TW201718016A (zh) | 聚合物及微球體 | |
| JP2025108532A (ja) | 非分解性の塞栓ミクロスフェア | |
| Zhang et al. | Polyethyleneimine-coated Fe3O4 nanoparticles for efficient siRNA delivery to human mesenchymal stem cells derived from different tissues | |
| Hu et al. | The effects of marsupialization on bone regeneration adjacent to keratocystic odontogenic tumors, and the mechanisms involved | |
| Watanabe et al. | A novel translational approach for human malignant pleural mesothelioma: heparanase-assisted dual virotherapy | |
| KR20220079600A (ko) | 비분해성 방사선 불투과성 색전술 미소구체 | |
| KR102075823B1 (ko) | 항암치료 및 유전자 치료용 나노입자를 포함하는 간동맥 화학색전술용 조성물 | |
| Taniyama et al. | Systemic malacoplakia in a breeding pig | |
| CN105131161B (zh) | 用于骨水泥的自显影聚甲基丙烯酸酯及自显影骨水泥的制备方法 | |
| KR20250029149A (ko) | 방사선 불투과성 단량체 및 이를 포함하는 색전술 미소구체 | |
| Sola et al. | Multifocal angiomyolipoma in a patient with tuberous sclerosis | |
| Patel et al. | Pharmaceuticals for intra-arterial therapy | |
| CA2990133C (en) | Compositions and methods for viral embolization | |
| TWI733564B (zh) | 骨水泥組成物 | |
| KR20210001294A (ko) | M1 대식세포로의 선택적 분화방법 | |
| DE102009043551B4 (de) | Implantatmaterial sowie Verfahren zu dessen Herstellung | |
| HK1252004B (en) | Compositions and methods for viral embolization |